文献速递儿科与产科急症重症综合管理与镇静镇痛

不同卫生系统内极早产儿结局差异

Outcomes for Very Preterm Infants Across Health Systems.
PubMed 文献 · JAMA Netw Open · 2025-06-02
一句话结论美国224个卫生系统内极早产儿(24-29周)调整后死亡率最高与最低四分位系统间相差2个百分点(7.8% vs 9.8%),存活儿平均住院时间相差12天(78天 vs 90天)。

该横断面研究基于Vermont Oxford Network美国成员医院数据,纳入224个卫生系统、2021年1月1日至2022年12月31日期间出生的38501名极早产儿(胎龄24-29周,中位27周)。采用多水平logistic和线性模型估计调整后死亡率和存活儿住院时间。最高绩效四分位系统平均调整死亡率为7.8%(95%CrI 7.3%-8.3%),最低绩效四分位为9.8%(95%CrI 9.1%-10.7%)。存活儿平均调整住院时间最高绩效四分位系统为78天(95%CrI 77-79天),最低绩效四分位为90天(95%CrI 88-91天)。作者认为这些差异具有潜在临床意义,卫生系统层面存在改善质量和降低资源使用的机会。

要点

  • 38501名极早产儿(胎龄24-29周,中位27周)中,91.0%在报告医院出生,95.4%在报告系统内出生。
  • 最高绩效四分位卫生系统平均调整死亡率为7.8%(95%CrI 7.3%-8.3%),最低绩效四分位为9.8%(95%CrI 9.1%-10.7%),相差2个百分点。
  • 存活儿平均调整住院时间在最高绩效四分位系统为78天(95%CrI 77-79天),最低绩效四分位为90天(95%CrI 88-91天),相差12天。
  • 两年期间每个卫生系统接诊极早产儿的中位数(IQR)为108(59-198)名。
  • 作者认为卫生系统层面存在改善质量以降低极早产儿死亡率和减少患者护理资源使用的机会。

适用人群与场景

  • 美国Vermont Oxford Network成员医院所属224个卫生系统中,2021年1月1日至2022年12月31日期间出生、胎龄24-29周的极早产儿,共38501名(中位胎龄27周,IQR 26-28周;52.8%为男孩)。
  • 暴露为在水平整合的多医院卫生系统中接受新生儿重症监护病房(NICU)护理。

研究设计与关键结果

  • 研究设计为横断面研究,数据来自Vermont Oxford Network美国成员医院,覆盖224个卫生系统,纳入38501名胎龄24-29周的极早产儿,出生日期为2021年1月1日至2022年12月31日。
  • 主要结局为死亡率和存活儿住院时间,采用多水平logistic和线性模型估计。
  • 最高绩效四分位卫生系统的平均调整死亡率为7.8%(95%CrI 7.3%-8.3%),最低绩效四分位为9.8%(95%CrI 9.1%-10.7%)。
  • 存活儿平均调整住院时间在最高绩效四分位系统为78天(95%CrI 77-79天),最低绩效四分位系统为90天(95%CrI 88-91天)。
  • 两年期间每个卫生系统接诊的极早产儿中位数(IQR)为108(59-198)名;91.0%在报告医院出生,95.4%在报告系统内出生。

证据类型、等级与局限

  • 证据类型:横断面研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,卫生系统层面存在改善质量以降低极早产儿死亡率和减少患者护理资源使用的机会。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: As a result of consolidation in the health care delivery system, most very preterm infants in the US are born and receive care in multihospital health systems. The extent of variation in patient outcomes and length of stay for this vulnerable population across health systems and across hospitals within systems is not known.

OBJECTIVE: To evaluate the extent of variation in mortality and length of stay within and across health systems for infants born very preterm (gestational age 24-29 weeks).

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study examined data contributed by Vermont Oxford Network US member hospitals in 224 health systems that delivered care to very preterm infants born between January 1, 2021, and December 31, 2022.

EXPOSURE: Receipt of neonatal intensive care unit (NICU) care in a horizontally integrated multihospital health system.

MAIN OUTCOMES AND MEASURES: Mortality rates and length of stay among surviving infants were estimated using multilevel logistic and linear models.

RESULTS: The sample included 38 501 infants (median [IQR] gestational age, 27 [26-28] weeks; 52.8% boys). The median (IQR) number of infants receiving care at a hospital system during the 2-year period was 108 (59-198); 91.0% were born at the reporting hospital, and 95.4% were born in the reporting system. The mean adjusted mortality rate in the highest performing quartile of systems was 7.8% (95% credible interval [CrI], 7.3%-8.3%) compared with 9.8% (95% CrI, 9.1%-10.7%) for the lowest performing quartile. The mean adjusted length of stay for surviving infants ranged from 78 days (95% CrI, 77-79 days) to 90 days (95% CrI, 88-91 days) between the highest and lowest performing quartiles of systems, respectively.

CONCLUSIONS AND RELEVANCE: In this cross-sectional study of very preterm infants, there was a 2-percentage point difference in mortality between systems in the highest and lowest performing quartiles and a 12-day difference in mean length of stay among surviving infants, which are potentially clinically meaningful. Opportunities exist for health systems to improve quality at the health system level to decrease mortality among infants born very preterm and reduce resources used in patient care.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Rogowski JA, Greenberg L, Edwards EM, et al. Outcomes for Very Preterm Infants Across Health Systems. JAMA Netw Open. 2025. PMID: 40455446. doi:10.1001/jamanetworkopen.2025.13274

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。